Back to search results

Telehealth Intervention for HIV Prevention and HCV Care in the Deep South

This study is testing a telehealth (virtual healthcare) program for people who inject drugs in the Deep South. The program, called "Trauma-informed, Resilience-based Telehealth Intervention," aims to improve HIV prevention (using PrEP), Hepatitis C (HCV) care, and treatment for opioid use disorder (MOUD). It helps you identify and manage stress, develop coping skills, and build resilience. We want to see if this program is practical, well-liked, and easy to use. You might be able to join if you are at least 18 years old, inject drugs, are HIV negative, and live in a rural area. The study plans to enroll 50 participants.

Study design
This is an interventional study with a waitlist-controlled, randomized pilot trial design, involving about 40 participants. It uses a cross-over design.
What's involved
You would participate in 8 weekly telehealth sessions, each lasting one hour, over eight consecutive weeks. You will also complete surveys before and after the intervention.
Compensation
Not stated in the trial record.
Follow-up
The primary outcomes (feasibility, acceptability, usability) are measured at Months 31-60. Secondary outcomes are assessed using pre- and post-intervention surveys.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06799702

Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)

Not Yet Recruiting
NAAges 18+InterventionalHealth services
University of Georgia
~50 participants
Updated 2025-12-18 on ClinicalTrials.gov
What's tested:Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of the Intervention
Measured over Months 31-60
+2 more outcomes measured

Conditions

HIV Pre-exposure Prophylaxis
HEPATITIS C (HCV)
Opioid Use Disorder

Explore related trials

Hepatitis C InfectionOpioid Use Disorder

Where it's being run

1 sites across 1 states
Georgia1

Who to contact

Mohammad Rifat Haider, Ph.D.
[email protected]
803-477-4289
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

People who actively inject drugs verified by visible injection stigmata (needle tracks)
HIV negative
Adult (≥18 years)
lives in rural areas

Exclusion

Living with HIV
Lives in urban areas
Not proficient in English

What this trial measures

  • Feasibility of the InterventionMonths 31-60

    Feasibility of the telehealth intervention will be assessed during baseline, at 2-months, and 4-months among both PWID and interventionists. Feasibility will be assessed by the completion rates of the interventionist training sessions and the participation/drop-out rates of the PWID.

  • Acceptability of the telehealth interventionMonths 31-60

    Acceptability of the telehealth intervention will be assessed during baseline, at 2-months, and 4-months among both PWID and interventionists. Acceptability will be examined by Likert scale like responses, e.g., "convenient," "a nuisance," "easy to use," and "time-consuming."

  • Usability of the telehealth interventionMonths 31-60

    Usability of the telehealth intervention will be assessed during baseline, at 2-months, and 4-months among both PWID and interventionists. Usability will be assessed with the USE questionnaire, which captures the perceived usefulness, satisfaction, and ease of use.